News

NCQA Data Aggregator Validation Expands to Include FHIR Exchange

Expansion of Available Output Files Reflects, Reinforces Health Care's Adoption of Fast Healthcare Interoperability Resources (FHIR®)WASHINGTON, DC / ACCESSWIRE /…

1 year ago

CorVive Sets Industry Benchmark with NSF Certification for its Cor Hydrate Electrolyte Drink Mix

PLANO, TX / ACCESSWIRE / August 8, 2023 / CorVive, a leading manufacturer of premium health and wellness products, is…

1 year ago

Inogen Recognized as a Finalist for Ragan’s CSR & Diversity Awards Program

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting,…

1 year ago

ModMed Women in Innovation & Technology and Pace Center for Girls Broward Empower High School Girls for Future Success in the Tech Industry

BOCA RATON, Fla.--(BUSINESS WIRE)--ModMed Women in Innovation & Technology (mmWIT) and Pace Center for Girls Broward have joined forces with…

1 year ago

NervGen Pharma to Proceed with Landmark Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury Having Completed FDA Review and Received IRB Approval

Recruitment of individuals with spinal cord injury (SCI) initiated at Shirley Ryan AbilityLab in ChicagoChronic SCI cohort results expected in…

1 year ago

Red Light Holland Announces Happy Caps Mushroom Farm Signs Distribution Deal with Longo Brothers Fruit Markets Inc. – Longo’s – Adding 31 Premium Grocery Locations in Southern Ontario

Happy Caps Mushroom Home Grow Kits will soon be available in over 135 retail stores across Canada, including Longo's 31…

1 year ago

Dr. Mark Huh Recognized for His Teaching by University of Pennsylvania School of Dental Medicine

Dr. Mark Huh recognized for his valued and dedicated teaching by University of Pennsylvania School of Dental MedicineCINNAMINSON, NJ /…

1 year ago

PaxMedica to Join Fireside Chat with PCG Advisory Following Positive Top Line Results from PAX-HAT-301 Study

PaxMedica to discuss significance of Phase 3 study resultsInterview to be webcast on Tuesday, August 15, 2023, at 10:30 am…

1 year ago

Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease

MVID is a life-threatening and ultra-rare autosomal recessive disease that affects newborns and children, leading to intestinal failure, significant morbidity…

1 year ago

Ensysce Biosciences Announces IRB Approval of Key Study Protocol

~ Approval of Study Represents Progression Toward Full Phase 3 Evaluation of PF614 ~~ Study to Assess PF614 Time of…

1 year ago